All Posts
  • Press Releases
1 min read

NextGen: Class of 2025

On this page

Share

BioSpace is proud to present its NextGen: Class of 2025, a list of the hottest new life sciences companies in the United States.

To come up with this list, BioSpace identified companies that announced initial, seed or series A rounds between October 1, 2023, and September 30, 2024. They were then assessed using several different criteria including finance, partnerships, pipeline, growth potential and innovation until the BioSpace editorial team came up with its top 25 picks.

Related Articles

Explore posts connected to this topic

View Resources

Bag of Tr1Xs: Off-the-Shelf Type 1 Treg Shows Phase I Promise for GvHD

In a clinical first, Tr1X Bio showed immune reconstitution and engraftment for allogeneic Tr1 cell therapy, establishing clinical safety and...

  • Interviews

Tr1X Presents First Clinical Data Demonstrating Proof of Safety and Proof of Mechanism With Allogeneic Off-the-Shelf Tr1 Regulatory T Cell Therapy TRX103

First clinical data from Phase 1 dose-escalation study in patients

  • Press Releases

The BioHub Podcast with David de Vries, Co-Founder, CEO, discussing Tr1X’s pipeline of Type-1 regulatory T cells

The BioHub Podcast with David de Vries, Co-Founder, CEO, discussing

  • Videos

In a clinical first, Tr1X Bio showed immune reconstitution and

  • Interviews

First clinical data from Phase 1 dose-escalation study in patients

  • Press Releases

The BioHub Podcast with David de Vries, Co-Founder, CEO, discussing

  • Videos